Remove co-creating-new-innovations
article thumbnail

Co-creating New Innovations

PharmExec

Pharma companies are teaming with academic institutions earlier in the R&D process.

Pharma 52
article thumbnail

New acquisition to support global gene therapy manufacturing

European Pharmaceutical Review

Ajinomoto Co., Impact of the acquisition agreement Timothy Miller, PhD, CEO, President, and Co-founder of Forge Biologics stated that the CDMO is “excited” to join Ajinomoto Co. The post New acquisition to support global gene therapy manufacturing appeared first on European Pharmaceutical Review.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CDMO expands ADC facility in Scotland

European Pharmaceutical Review

Piramal Pharma Solutions has officially opened new facilities at its antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. We see the market gravitating towards large and commercial scale manufacturing, which the new facility is well equipped to address,” he added.

article thumbnail

Reaching New Global ‘Frontiers’ In Life Sciences

Eversana Intouch

Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy. With sessions focused on the themes of digital health, therapeutics, and innovation, EVERSANA subject matter experts were featured speakers alongside our new Healthware colleagues across eight sessions.

article thumbnail

InvisiShield and Gladstone partner to develop intranasal preventatives

Pharmaceutical Technology

InvisiShield Technologies’ president, chief scientific officer and co-founder Dr Warner Greene said: “We are excited to be collaborating with Gladstone to develop intranasal preventatives for three of the most significant respiratory viral infections, SARS-CoV-2, influenza and RSV.

Safety 115
article thumbnail

Life sciences sector to receive £650 million funding

European Pharmaceutical Review

Steve Bates OBE, CEO of the Bioindustry Association welcomed the initiatives, “including those that will improve access to finance for start-ups and scale-ups, and to create a pro-innovation regulatory environment. The post Life sciences sector to receive £650 million funding appeared first on European Pharmaceutical Review.

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

PhRMA is lying to protect its profits, and the lies have reached a new height as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act. Of course, the drug industry warns that any price negotiation will kill innovation. This is, of course, pure b t. In 2021 alone, the top U.S.

Pharma 255